Skip to main content
. Author manuscript; available in PMC: 2008 Dec 5.
Published in final edited form as: J Med Chem. 2006 Oct 19;49(21):6290–6297. doi: 10.1021/jm060647f

Fig 8.

Fig 8

HuCC49ΔCH2-β-galactosidase conjugate binds to cancer cells and activates 17-AG-C2-Gal to release active drug 17-AG-C2 that enters the cancer cell and binds to Hsp90 to induce AKT degradation.